Definitive Contract 36C26223C0013
Award Date
10/1/22
Potential Completion Date
11/30/23
Potential Value
$2.9M
Federal Agency
Veterans Integrated Service Network 22
Awardee
RLS (USA) Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Long Beach, CA 90822, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm-fixed-price contract with a ceiling value of $852,160.60 was awarded by the Department of Veterans Affairs (VA) to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company, to provide radiopharmaceuticals to the VA Long Beach Healthcare System in Long Beach, California. The contract has a base term of one year and four one-year option periods, with a total potential performance period through November 30, 2025. The contract was awarded under an unrestricted solicitation that...
This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company. The contract, valued at $1,395,620.34, is for the delivery of radiopharmaceuticals such as gallium-67, fluorodeoxyglucose F-18, thallium-201, technetium-99m, and Gallium-68 Dotatate to support nuclear medicine diagnostic services at VA medical centers. The contract is not set aside and was awarded on February 28, 2020, with...
This is a definitive contract awarded by the Department of Veterans Affairs (VA) to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company, for the supply of radiopharmaceuticals and related services. The $878,999.37 firm-fixed price contract is not set aside and has an ultimate completion date of September 17, 2024. RLS (USA) Inc. specializes in providing a wide range of molecular imaging products, including medical isotopes and radiopharmaceuticals, to support nuclear medicine...
This firm-fixed price federal contract award, valued at $425,794.77, was issued by the Department of Veterans Affairs (VA) to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company. The contract is for the provision of radiopharmaceuticals and related services to support nuclear medicine diagnostic procedures at VA medical centers and military treatment facilities over a 6-month period ending in July 2024. RLS (USA) Inc. operates a nationwide network of 31 radiopharmacy facilities,...
This is a $3,952,644.98 definitive contract awarded by the Department of Veterans Affairs (VA) to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company, to provide single-photon emission radiopharmaceuticals to the Atlanta VA Health Care System in Decatur, Georgia. The contract has a performance period of July 12, 2024 through July 11, 2029 and is a firm fixed-price contract. It was awarded as a total small business set-aside under NAICS code 325412 (Pharmaceutical Preparation...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a $607,676.91 firm fixed price delivery order contract to RLS USA Inc., a foreign-owned for-profit radiopharmacy company. The contract is for the provision of radiopharmaceuticals, such as gallium-67, fluorodeoxyglucose F-18, thallium-201, and technetium-99m, to support nuclear medicine services at the Milwaukee VA Medical Center. This delivery order contract is likely part of a...
This federal contract award is to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company, for the delivery of radiopharmaceuticals such as gallium-67, fluorodeoxyglucose F-18, thallium-201, technetium-99m, and Gallium-68 Dotatate. The contract, valued at $216,261.99, is a Delivery Order under a larger Indefinite Delivery Vehicle (IDV) with the Department of Veterans Affairs (VA) and the Defense Health Agency (DHA). RLS (USA) Inc. operates 31 radiopharmacy facilities across 18...
This is a $425,725.07 firm fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company. The contract is for the supply of non-pet radiopharmaceuticals to support nuclear medicine diagnostic services at VA medical centers. It has a performance period from April 1, 2025 to March 31, 2026. The contract is not a set-aside. RLS (USA) Inc. is a small business that specializes in providing...
This firm-fixed-price delivery order contract was awarded to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company, by the Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 17. The contract is for the provision of radiopharmaceuticals, including gallium-67, fluorodeoxyglucose F-18, thallium-201, technetium-99m, and Gallium-68 Dotatate, which are critical for nuclear medicine imaging procedures and diagnostic services provided to veterans and military...
The U.S. Department of Veterans Affairs (VA) has awarded a firm-fixed price delivery order contract to RLS (USA) Inc., a foreign-owned for-profit radiopharmacy company, for the supply of non-pet radiopharmaceuticals. The contract, valued at $232,388.97, has an ultimate completion date of March 31, 2025. RLS (USA) Inc. is a small business that specializes in providing a range of medical isotopes and radiopharmaceutical products to support nuclear medicine diagnostic services at VA medical centers...